Please login to the form below

Not currently logged in
Email:
Password:

Bayer names head of US litigation

Malini Moorthy joins from Pfizer

bayer-malini-moorthyGerman life sciences group Bayer has named Pfizer's Malini Moorthy as head of US litigation.

Moorthy succeeds Kaspar Stoffelmayr in heading all major litigation matters in the US for all Bayer's divisions, including Bayer Healthcare and Bayer CropScience. She will report to Lars Benecke, Bayer's general counsel.

In her most recent role Moorthy served as VP and assistant general counsel and head of civil litigation at Pfizer in the US. She spent 10 years at Pfizer in senior legal roles having joined the company in 2004 from law firm Salans.

“As a highly successful and respected lawyer, Malini comes to us with a proven track record in the litigation field,” said Benecke. “She is an impressive leader who will greatly enrich the Bayer legal team."

Moorthy's personal accolades include being named to Inside Counsel magazine's R3-100 List identifying the 100 leading female attorneys most likely to become general counsels within three years.

Before commencing her law career Moorthy served as executive director of Free the Children in Toronto, an international children's organisation dedicated to ending the exploitation of children throughout the world.

17th July 2014

From: Regulatory

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Life Healthcare Communications

Life is a creative communications agency offering multi-channel solutions for the healthcare industry. We use a storytelling approach to turn...

Latest intelligence

The UK’s new five-year pricing agreement
Pharma has agreed to capped growth again - in exchange for uptake promises...
Digital applications are transforming the market access landscape
Organisations are leveraging new technology to implement a wider range of business models and, in essence, drive market access success by working smarter, faster and with greater economy....
Escaping the spin cycle of sub-optimal launch
...

Infographics